Search research articles
Contact Us
Filters
Showing results (211-220 of 289) with videos related to
Page
of 29
Sort By:
Clinical Genitourinary Cancer
|
September 19, 2015
Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme
Francesca Maines, Orazio Caffo, Ugo De Giorgi, et al.
BJU International
|
July 4, 2014
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme
Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al.
Journal of Geriatric Oncology
|
August 13, 2025
Effectiveness of nivolumab-based immunotherapy and prognostic stratification by the Meet-URO score in real-world older patients with metastatic renal cell carcinoma
Veronica Murianni, Marina Campione, Malvina Cremante, et al.
European Urology
|
March 7, 2017
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2022
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA
Nobuaki Matsubara, Johann de Bono, David Olmos, et al.
JCO Precision Oncology
|
May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial
Andrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
Journal for Immunotherapy of Cancer
|
April 5, 2019
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
Elena Verzoni, Giacomo Cartenì, Enrico Cortesi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
Vincenzo Nasca, Natalie Prinzi, Jorgelina Coppa, et al.
European Urology Oncology
|
April 29, 2025
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study
Martina Buffoni, Alberto Dalla Volta, Francesca Valcamonico, et al.
Annals of Surgical Oncology
|
December 5, 2014
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors
Matteo Santoni, Alessandro Conti, Stefano Partelli, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 289) with videos related to
Sort By:
Page
of 29
Clinical Genitourinary Cancer
|
September 19, 2015
Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme
Francesca Maines, Orazio Caffo, Ugo De Giorgi, et al.
BJU International
|
July 4, 2014
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme
Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al.
Journal of Geriatric Oncology
|
August 13, 2025
Effectiveness of nivolumab-based immunotherapy and prognostic stratification by the Meet-URO score in real-world older patients with metastatic renal cell carcinoma
Veronica Murianni, Marina Campione, Malvina Cremante, et al.
European Urology
|
March 7, 2017
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2022
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA
Nobuaki Matsubara, Johann de Bono, David Olmos, et al.
JCO Precision Oncology
|
May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial
Andrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
Journal for Immunotherapy of Cancer
|
April 5, 2019
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
Elena Verzoni, Giacomo Cartenì, Enrico Cortesi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
Vincenzo Nasca, Natalie Prinzi, Jorgelina Coppa, et al.
European Urology Oncology
|
April 29, 2025
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study
Martina Buffoni, Alberto Dalla Volta, Francesca Valcamonico, et al.
Annals of Surgical Oncology
|
December 5, 2014
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors
Matteo Santoni, Alessandro Conti, Stefano Partelli, et al.
Page
of 29